
With 3/4th Revenue Share Interventional Studies to Continue Being the Prominent Revenue Stream in Omics Based Clinical Trials Market, Mentions Fact.MR
The Omics Based Clinical Trials Market revenues were estimated at US$ 26.2 Bn in 2021 and is anticipated to grow at a CAGR of 8.1% from 2022-2032, according to a …
With 3/4th Revenue Share Interventional Studies to Continue Being the Prominent Revenue Stream in Omics Based Clinical Trials Market, Mentions Fact.MR Read More